A.G.P. is lead placement agent. Laidlaw & Company is co-placement agent. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended by analysts >> Read More on PTN: Palatin says BMT-801 Phase 2 obesity study met primary endpoint Biotech Alert: Searches spiking for these stocks today Palatin reports ‘positive’ results from Phase 2 study of PL8177 Palatin: FDA grants orphan drug designation to PL7737 Palatin Technologies Reports Q2 2025 Financial Results Disclaimer & DisclosureReport an Issue
